Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Pharmacy topic

No spam. Unsubscribe anytime.

Medical board balks at practitioner-controlled stock for controls in prisons, approves non-controlled stock plan

Arkansas State Medical Board · December 4, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

After a lengthy debate over methods for supplying medications to people in state correctional facilities, the board rejected physician-held controls but allowed non-controlled stock dispensing with pharmacy oversight; concerns about missing controlled substances at other sites drove the decision.

The Arkansas State Medical Board debated whether prison clinics should use physician-held DEA stock for controlled substances or rely on facility DEA or remote-pharmacy models. Pharmacy contractor representatives described three compliance models: a facility-level DEA for the site, pharmacy-held remote stock, or practitioner-controlled stock tied to an individual physician's DEA.

Board members repeatedly raised past incidents of missing controlled medicines at correctional facilities and warned that allowing individual physicians to hold and dispense controlled stock would expose them to high professional and criminal liability. One member said, "If something comes up missing under your name and that came before this board, not good." The board also discussed alternatives such as requiring facilities to obtain a DEA registration tied to the site and using pharmacy-managed emergency boxes.

After discussion, motion and votes, the board approved a plan that permits dispensing permits for non-controlled stock at correctional clinics but refused to approve practitioner-held controlled stock. The board asked the contractor and DOC to return with documentation for facility DEA options and to coordinate with the Pharmacy Board as needed.

What happens next: The contractor will revise proposals to remove controls from the physician-held model and to explore facility DEA or pharmacy remote-stock arrangements; the board will track follow-up and may request more documentation from pharmacy regulators.